Recorded Chinese product: 盐酸克仑特罗吸入粉雾剂盐酸克仑特罗吸入粉雾剂
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 重庆和平制药有限公司Chinese legal name: 重庆和平制药有限公司
主要成分Active Ingredients
- 克仑特罗Kelun Teluo
药物知识说明
克仑特罗是一种在国家药监局注册认定的药品。该药品含有克仑特罗-ae9b2b6a等成分。
该药品关联的活性成分包括:克仑特罗Kelun Teluo。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:重庆和平制药有限公司Chinese legal name: 重庆和平制药有限公司。
您可以探索含有相同成分的其他药品:克仑特罗-ae9b2b6a成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 盐酸克仑特罗吸入粉雾剂) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 克仑特罗Kelun Teluo.
Manufacturers recorded for this product: 重庆和平制药有限公司Chinese legal name: 重庆和平制药有限公司.
Explore other medicines containing the same ingredient: 克仑特罗 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 盐酸克仑特罗吸入粉雾剂Recorded Chinese product: 盐酸克仑特罗吸入粉雾剂
- 规格Specification: 20μg20 μg
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 重庆和平制药有限公司Chinese legal name: 重庆和平制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20080486
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20080486
Manufacturer
Chinese legal name: 重庆和平制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20080486
生产企业
重庆和平制药有限公司(国产)
适应症
用于缓解支气管哮喘以及喘息型慢性支气管炎所致的支气管痉挛。
用法用量
吸入给药,一般作为临时用药,有哮喘发作预兆或哮喘发作时使用。一次20μg(1粒),1日3次,每次给药间隔不得少于4小时
不良反应
针对本品完成的临床试验中可见心悸、失眠、头痛、头晕、咽痛不适、恶心呕吐、肌颤等不良反应发生。
禁忌
对本品及其他肾上腺素能受体激动剂过敏者禁用,对乳糖过敏者禁用
注意事项
1.心律失常、高血压和甲状腺功能亢进症患者慎用。|2.矛盾性支气管痉挛:本品可产生威胁生命的矛盾性支气管痉挛。如果发生此症,应立即停药并换用其他治疗方法。|3.心血管作用:β-肾上腺素能激动剂使用经验表明,在测定脉搏、血压和/或症状时,一些患者可产生临床显著的心血管作用。尽管按推荐剂量使用本品时这种作用并不常见,如果发生,应停药。另外,β-肾上腺素能类药物有产生心电图变化的报道,例如T波变平、QTc间期延长、ST段压低。因此,心血管病患者慎用本品,特别是冠状动
贮藏
密封,置阴凉处。
规格
20μg
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.